SOLIGENIX, INC. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2020-12-10

Reporting Person: Straube Richard (CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-10	Option (Right to Buy)	$2.34	A	40000	Acquired	2030-12-09	Common Stock (40000)	Direct

Footnotes

F1: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020.